MwanzoROG • SWX
add
Roche Holding AG Genussscheine
Bei iliyotangulia
CHFÂ 374.00
Bei za siku
CHFÂ 368.50 - CHFÂ 373.90
Bei za mwaka
CHFÂ 231.90 - CHFÂ 374.90
Thamani ya kampuni katika soko
327.76B CHF
Wastani wa hisa zilizouzwa
1.04M
Uwiano wa bei na mapato
23.01
Mgao wa faida
2.66%
Ubadilishanaji wa msingi
SWX
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 15.75B | -0.42% |
Matumizi ya uendeshaji wa biashara | 6.82B | -6.61% |
Mapato halisi | 2.74B | 170.93% |
Kiwango cha faida halisi | 17.36 | 172.10% |
Mapato kwa kila hisa | — | — |
EBITDA | 5.50B | 5.93% |
Asilimia ya kodi ya mapato | 19.20% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 15.49B | -10.66% |
Jumla ya mali | 100.70B | -1.08% |
Jumla ya dhima | 62.82B | -4.29% |
Jumla ya hisa | 37.88B | — |
hisa zilizosalia | 795.62M | — |
Uwiano wa bei na thamani | 8.80 | — |
Faida inayotokana na mali | 11.73% | — |
Faida inayotokana mtaji | 16.62% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.74B | 170.93% |
Pesa kutokana na shughuli | 5.88B | -3.51% |
Pesa kutokana na uwekezaji | -5.19B | -21.67% |
Pesa kutokana na ufadhili | -1.62B | -136.86% |
Mabadiliko halisi ya pesa taslimu | -986.00M | -191.68% |
Mtiririko huru wa pesa | 2.53B | 15.49% |
Kuhusu
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel.
Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76.
The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021.
F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Okt 1896
Makao Makuu
Tovuti
Wafanyakazi
112,774
